2018 Annual Meeting | C223 - The Burden of Epilepsy: Managing Comorbidities and Quality of Life

Date Friday 04/27/18

Time 07:00 AM - 09:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Gregory D. Cascino, MD, FAAN

Topic(s)

Learning Objectives Participants should become familiar with the current recommendations for the evaluation and treatment of comorbid conditions that occur in people with epilepsy, including language and cognitive disorders, behavioral problems, depression, and complications of treatment. Clinical pearls to screen patients for significant mood disorders that may be associated with suicide will be provided. The risks, prevalence, and possible prevention of sudden unexplained death in epilepsy (SUDEP) will be presented.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Tracks Advanced Practice Provider

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic

Event Timeline
07:00 AM - 07:20 AM	Introduction	Gregory D. Cascino, MD, FAAN
07:20 AM - 07:50 AM	Speaker	Adverse Effects of Antiepileptic Drug Therapy and Comorbidities
07:50 AM - 08:20 AM	Speaker	Cognitive and Psychiatric Issues Associated with Seizure Disorders Kimford J. Meador, MD, FAAN
08:20 AM - 08:50 AM	Speaker	SUDEP Update: Mechanisms, Disclosure, Guidelines Jeffrey R. Buchhalter, MD, FAAN
08:50 AM - 09:00 AM	Q&A	Questions and Answers Gregory D. Cascino, MD, FAAN

Faculty Disclosures
Gregory D. Cascino, MD, FAAN	Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care.
Jeffrey R. Buchhalter, MD, FAAN	Dr. Buchhalter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Foundation. Dr. Buchhalter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epilepsy Study Consortium. Dr. Buchhalter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epilog. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shackelford Pharmaceuticals. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex.
Kimford J. Meador, MD, FAAN	The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from Eisai. The institution of Dr. Meador has received research support from Medtronics. The institution of Dr. Meador has received research support from The Epilepsy Consortium.
	No disclosure on file